Octant Bio

Octant

The company develops small molecule precision medicines for patients with genetic diseases using biology, chemistry and computation.

Integrated Biosciences

The company develops small-molecule therapies for age-related diseases using a synthetic biology and machine learning platform to target cellular stress responses.

AI-enabled drug design

This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.

Ten63 Therapeutics

This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.

Dogma Biotech

This company develops AI-designed glycans to enhance protein therapeutic performance for patients with central nervous system and lysosomal storage diseases.

Enveda Bioscience

This company develops small molecule medicines for patients with inflammatory and metabolic diseases by using machine learning to map natural plant chemistry.

Think Bioscience

This company develops small-molecule therapeutics for pharmaceutical researchers by using synthetic biology and engineered microbes to target difficult-to-drug proteins.

Congruence Therapeutics

This biotechnology company develops small molecule medicines for patients with metabolic, neurological, immunological and oncological diseases using machine learning and biophysics.